Related references
Note: Only part of the references are listed.Pathology, diagnostics, and classification of medulloblastoma
Brent A. Orr
BRAIN PATHOLOGY (2020)
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
Kulandaimanuvel Antony Michealraj et al.
CELL (2020)
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan et al.
NATURE MEDICINE (2020)
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner et al.
MOLECULAR THERAPY (2020)
Medulloblastoma in the age of molecular subgroups: a review
Kyle Juraschka et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2019)
Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma
Liang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
Xun Huang et al.
CELL (2018)
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner et al.
CELL REPORTS (2018)
Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brgl
Tao Wu et al.
CELL REPORTS (2018)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma
BaoHan T. Vo et al.
CELL REPORTS (2017)
Combination of palbociclib and radiotherapy for glioblastoma
Shane Whittaker et al.
CELL DEATH DISCOVERY (2017)
Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models
Michelle L. Cook Sangar et al.
CLINICAL CANCER RESEARCH (2017)
In vitro models of medulloblastoma: Choosing the right tool for the job
Delyan P. Ivanov et al.
JOURNAL OF BIOTECHNOLOGY (2016)
EphA2 is a functional receptor for the growth factor progranulin
Thomas Neill et al.
JOURNAL OF CELL BIOLOGY (2016)
Survival After Relapse of Medulloblastoma
Carl Koschmann et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Michael Goldstein et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Paediatric brain tumours: A review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy
A. Laprie et al.
CANCER RADIOTHERAPIE (2015)
Ephrin type-A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3-kinase/Akt signalling pathway
Yunyun Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
Patterns of Failure After Proton Therapy in Medulloblastoma: Linear Energy Transfer Distributions and Relative Biological Effectiveness Associations for Relapses
Roshan V. Sethi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Vijay Ramaswamy et al.
LANCET ONCOLOGY (2013)
Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair
Michael Goldstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genomic occupancy of the transcriptional co-activators p300 and CBP
Per-Henrik Holmqvist et al.
TRANSCRIPTION-AUSTIN (2013)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
Daisuke Kawauchi et al.
CANCER CELL (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
EZH2 silencing with RNAi enhances irradiation-induced inhibition of human lung cancer growth in vitro and in vivo
Hui Xa et al.
ONCOLOGY LETTERS (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells
Nai-Ying Yang et al.
CELLULAR SIGNALLING (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Challenging issues in pediatric oncology
Ching-Hon Pui et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
Hui Miao et al.
CANCER CELL (2009)
Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
Hui-Fang Li et al.
RADIATION ONCOLOGY (2009)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells
M Zeidler et al.
NEOPLASIA (2005)
β-catenin status predicts a favorable outcome in childhood medulloblastoma:: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Two molecularly distinct G2/M checkpoints are induced by ionizing irradiation
B Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
